PMC:7461420 / 16688-16773
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T99 | 64-67 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T187 | 42-49 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T115 | 42-49 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
T116 | 64-84 | Chemical | denotes | HIV fusion inhibitor | http://purl.obolibrary.org/obo/CHEBI_59886 |
T117 | 75-84 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T171 | 0-85 | Sentence | denotes | Enfuvirtide (T‐20) is an FDA approved HR2 peptide and the first HIV fusion inhibitor. |